Texcol Ex 120ml Syrup
₨ 160
About this product
Overview
Texcol Ex 120ml syrup contains the active ingredient Acefylline, which is a bronchodilator and a xanthine derivative. It is formulated as an oral syrup, designed to provide relief from respiratory symptoms and aid in the management of certain respiratory conditions.
Uses
- Bronchial Asthma: Texcol Ex syrup is primarily prescribed for the treatment of bronchial asthma, a chronic respiratory condition characterized by airway inflammation and constriction, leading to difficulty in breathing.
- Chronic Obstructive Pulmonary Disease (COPD): It is used to manage chronic obstructive pulmonary disease, a progressive lung disease that includes chronic bronchitis and emphysema.
- Bronchitis: Texcol Ex syrup may be used in the treatment of acute bronchitis, an infection of the airways causing cough, mucus production, and shortness of breath.
Side Effects
Acefylline is generally well-tolerated, but some individuals may experience side effects. Common side effects of Texcol Ex 120ml syrup may include:
- Nausea and Vomiting: Some users may experience mild to moderate nausea or vomiting.
- Headache: Acefylline may cause mild to moderate headaches in some individuals.
- Heartburn or Indigestion: Texcol Ex syrup may lead to heartburn or indigestion.
- Tremors: Some individuals may experience mild tremors or jitteriness.
- Insomnia: Acefylline may lead to difficulty falling asleep or disrupted sleep patterns in some patients.
- Palpitations: Rarely, individuals may experience a sensation of rapid or irregular heartbeats.
When Not to Use
- Allergy: Texcol Ex 120ml syrup should not be used in individuals with a known hypersensitivity or allergy to Acefylline or related xanthine derivatives.
- Seizure Disorders: It should be used with caution in patients with a history of seizure disorders.
- Peptic Ulcers: Texcol Ex syrup should be used with caution in individuals with peptic ulcers or a history of gastrointestinal bleeding.
Important Note: Texcol Ex 120ml syrup is a prescription medication that should only be used under the guidance and supervision of a healthcare professional. Dosage adjustments and regular monitoring are essential during treatment. Avoid taking other xanthine derivatives or caffeine-containing products while using this syrup.
Always inform your healthcare provider about any existing medical conditions or medications you may be taking before starting Texcol Ex syrup to avoid potential interactions or contraindications. If you experience any severe or persistent side effects, inform your healthcare provider promptly. Regular monitoring and follow-up with the healthcare provider are crucial during the course of treatment with this syrup.
This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.
Substitutes for Texcol Ex 120ml Syrup
These medicines contain the same salt as Texcol Ex 120ml Syrup (Acefylline 120ml), so they are common substitutes. Compare their prices, and change brands only after checking with your doctor or pharmacist.
| Medicine | Manufacturer | Pack | Price |
|---|---|---|---|
| Resfyl Syrup 120ml | Rasco Pharma Lahore | 1 | Rs 69.15 |
| Cefyl Esf Syrup 120ml | Epla Laboratories | 120ML | Rs 89.10 |
| Cefyl P Syrup 120ml | Epla Laboratories | 120ML | Rs 95.66 |
| Texcol Ex Syrup 120ml | Raazee Therapeutics | 120ML | Rs 105 |
| Acefyl 120ml Cough Syrup | Nabiqasim Industries | - | Rs 219 |
| Acefyl 120 Ml Syrup | Nabiqasim Industries | - | Rs 250 |
Other strengths of Acefylline
| Medicine | Manufacturer | Strength | Price |
|---|---|---|---|
| Bronkonorm 125 mg syrup | Werrick Pharmaceuticals | 125mg | Rs 53.35 |
| Broncophyline 125mg Syrup | Wilson's Pharmaceuticals | 125mg | Rs 77 |
| Acefyl 90ml Syp | Nabiqasim Industries | 90ml | Rs 99 |
| Brophyl 125 mg syrup | Stanely | 125mg | Rs 148.82 |
See all brands and prices on our Acefylline page.
Customer reviews
You must be logged in to post a review.
Reviews
Clear filtersThere are no reviews yet.